Comparing WhiteHorse Finance (NASDAQ:WHF) & Advanced Medical Isotope (OTCMKTS:RDGL)

WhiteHorse Finance (NASDAQ:WHF) and Advanced Medical Isotope (OTCMKTS:RDGL) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for WhiteHorse Finance and Advanced Medical Isotope, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WhiteHorse Finance	2	3	0	0	1.60
Advanced Medical Isotope	0	0	0	0	0.00

WhiteHorse Finance currently has a consensus price target of $7.75, suggesting a potential upside of 9.31%. Given WhiteHorse Finance’s stronger consensus rating and higher probable upside, research analysts plainly believe WhiteHorse Finance is more favorable than Advanced Medical Isotope.

Earnings & Valuation

This table compares WhiteHorse Finance and Advanced Medical Isotope”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WhiteHorse Finance	$92.82 million	1.78	$10.85 million	$0.43	16.49
Advanced Medical Isotope	$30,000.00	1,008.15	-$2.91 million	N/A	N/A

WhiteHorse Finance has higher revenue and earnings than Advanced Medical Isotope.

Institutional and Insider Ownership

13.2% of WhiteHorse Finance shares are owned by institutional investors. 2.5% of WhiteHorse Finance shares are owned by company insiders. Comparatively, 18.5% of Advanced Medical Isotope shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares WhiteHorse Finance and Advanced Medical Isotope’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
WhiteHorse Finance	12.91%	9.93%	4.14%
Advanced Medical Isotope	-6,144.90%	N/A	-113.56%

Risk and Volatility

WhiteHorse Finance has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, Advanced Medical Isotope has a beta of -0.5, meaning that its share price is 150% less volatile than the S&P 500.

Summary

WhiteHorse Finance beats Advanced Medical Isotope on 9 of the 11 factors compared between the two stocks.

About WhiteHorse Finance

WhiteHorse Finance, Inc. is business development company, non-diversified, closed end management company specializing in originating senior secured loans, lower middle market, growth capital industries. It invests in broadline retail, office services and supplies, building products, health care services, health care supplies, research and consulting services, application software, home furnishings, specialized consumer services, data processing and outsourced services, leisure facilities, cable, and satellite. It prefers to invest in United States. It typically invests between $5 million to $25 million in companies having enterprise value of between $50 million and $350 million.

About Advanced Medical Isotope

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.